Number of Birth Injury Lawsuits Filed Rising Over Zofran Drug Use During Pregnancy
In recent years major research studies have linked the anti-nausea drug, Zofran, to congenital heart defects. Almost two million birth records from Denmark and Sweden were reviewed by researchers who found babies exposed to the drug during their first trimester more than doubled their risk of "cardiac septal defects," according to the global news site Digitaljournal.com.
Today many of the mothers affected, who were prescribed Zofran as an "off-label" treatment to their morning sickness, have filed birth injury lawsuits against the drug's pharmaceutical company, GlaxoSmithKline. Reports indicate there are currently 34 individual motions filed in federal courts.
One Ohio law firm, Monheit Law, has started the website Zofranlegal.com where this particular case, among others, is made pub...